These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29950314)

  • 1. Variation in analytic transparency in recent efficacy studies of antidepressant medication.
    Vannoy S; Brodt M; Cosgrove L; Shaughnessy AF
    BMJ Evid Based Med; 2018 Oct; 23(5):177-182. PubMed ID: 29950314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
    Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
    J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of major depression in late life: what is the role of new agents?
    Patel K; Abdool PS; Rajji TK; Mulsant BH
    Expert Opin Pharmacother; 2017 Apr; 18(6):599-609. PubMed ID: 28317392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
    Girardi P; Pompili M; Innamorati M; Mancini M; Serafini G; Mazzarini L; Del Casale A; Tatarelli R; Baldessarini RJ
    Hum Psychopharmacol; 2009 Apr; 24(3):177-90. PubMed ID: 19229839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.
    Deardorff WJ; Grossberg GT
    Expert Opin Pharmacother; 2014 Dec; 15(17):2525-42. PubMed ID: 25224953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.
    Song J; Boscardin WJ; Furst DE; Khanna D; Wong WK
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-122-6. PubMed ID: 25372798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: the 15-min challenge to sort these agents out.
    Citrome L
    Int J Clin Pract; 2015 Feb; 69(2):151-5. PubMed ID: 25627335
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research.
    Gaudiano BA; Herbert JD
    Psychother Psychosom; 2005; 74(1):17-25. PubMed ID: 15627852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
    Beckett RD; Loeser KC; Bowman KR; Towne TG
    BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
    Baune BT; Sluth LB; Olsen CK
    J Affect Disord; 2018 Mar; 229():421-428. PubMed ID: 29331703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
    Vieta E; Sluth LB; Olsen CK
    J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Balk F; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004044. PubMed ID: 16235348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatry should not become hostage to placebo: an alternative interpretation of antidepressant-placebo differences in the treatment response in depression.
    Rihmer Z; Dome P; Baldwin DS; Gonda X
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):782-6. PubMed ID: 22497852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.